Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $141.7700 (-0.62%) ($140.3700 - $142.4900) on Tue. Sep. 20, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.36% (three month average) | RSI | 64 | Latest Price | $141.7700(-0.62%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV advances 0.5% a day on average for past five trading days. | Weekly Trend | ABBV advances 2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(30%) DIA(25%) SPLV(23%) XLP(22%) VYM(21%) | Factors Impacting ABBV price | ABBV will decline at least -0.68% in a week (0% probabilities). VIXM(-15%) UUP(-15%) TBT(-5%) UNG(-2%) VXX(2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.68% (StdDev 1.36%) | Hourly BBV | -0.6 () | Intraday Trend | -0% | | | |
|
5 Day Moving Average | $142.11(-0.24%) | 10 Day Moving Average | $141.26(0.36%) | 20 Day Moving Average | $139.25(1.81%) | To recent high | -8% | To recent low | 5.4% | Market Cap | $250.122b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |